Pharmaceutical Composition Comprising Compound Capable of Penetrating Blood-Brain Barrier as Effective Ingredient for Preventing or Treating Brain Cancer

(canceled)

5-7. (canceled)

(canceled)

(canceled)

14-21. (canceled)

A pharmaceutical kit for preventing or treating brain cancer, comprising:

• a first component containing a pharmaceutically effective amount of an LRRK2 protein inhibitor as an active ingredient;
• and
• a second component containing a pharmaceutically effective amount of Avastin as an active ingredient.

(canceled)

A method of treating a subject having a brain cancer, comprising:

• administering an effective amount of an LRRK2 (leucin-rich repeat kinase-2) protein inhibitor to the subject;
• and
• administering an effective amount of Avastin to the subject.

(canceled)